Prediction of , index 1525
Prospective Prediction
- Prediction Index
- 1525
- Prediction Date
- Commercial Prediction
- FAILURE (commercially insufficient additive clinical benefit to SoC with inferior-to-semaglutide efficacy in KCCQ-CSS and 6MWD)
- Technical Prediction
- partial SUCCESS (statistically maybe significant yet weak additive clinical benefit to SoC in KCCQ-CSS and 6MWD)
Readout of
Prediction Validation
- Readout Date
- Prediction To Readout
- 897 days in advance
- Readout Data Interpretation
- ziltivekimab deemed unlikely to succeed by the data monitoring committee and was discontinued further development;
- Press Release
- Press Release (statnews.com)
Prediction Result
- Prediction Accuracy
- Correct Prediction
- Clinical Benefit Conclusion
- statistically insignificant and commercially insufficient
- Prediction Classification
- True Negative (TN)